Weiss Multi-Strategy Advisers’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio KERX Stock Details KERX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-67,929	Closed	-$255K	–	733
2018 Q2	$255K	Buy	67,929 +5,929	+10%	+$28.9K	0.01%	513
2018 Q1	$254K	Sell	62,000 -2,000	-3%	-$9.31K	0.01%	495
2017 Q4	$298K	Hold	64,000	–	–	0.01%	522
2017 Q3	$454K	Hold	64,000	–	–	0.02%	434
2017 Q2	$463K	Sell	64,000 -1,000	-2%	-$6.25K	0.02%	456
2017 Q1	$400K	Buy	65,000 +1,000	+2%	+$5.48K	0.02%	480
2016 Q4	$375K	Hold	64,000	–	–	0.02%	352
2016 Q3	$340K	Sell	64,000 -1,610	-2%	-$8.68K	0.02%	368
2016 Q2	$434K	Sell	65,610 -45,390	-41%	-$254K	0.03%	332
2016 Q1	$518K	Hold	111,000	–	–	0.02%	383
2015 Q4	$561K	Hold	111,000	–	–	0.04%	296
2015 Q3	$391K	Buy	+111,000	New	+$743K	0.02%	335
2015 Q1	–	Sell	-10,000	Closed	-$142K	–	568
2014 Q4	$142K	Buy	+10,000	New	+$155K	﹤0.01%	386
2014 Q1	–	Sell	-14,100	Closed	-$183K	–	1190
2013 Q4	$183K	Buy	+14,100	New	+$168K	﹤0.01%	915

Other funds holding KERX

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

PIMJS

PKO Investment Management Joint-Stock Warsaw, Poland $1.38B AUM 59.54% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Weiss Multi-Strategy Advisers's KERX Position: Q3 2018 in Review

Weiss Multi-Strategy Advisers sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2018, closing a stake of 67,929 shares — an estimated $255K sold.

Weiss Multi-Strategy Advisers first reported a position in KERX in Q4 2013 and held it in 14 quarters. The position peaked at $561K in Q4 2015. 123 funds tracked by Wall St. Rank hold KERX as of Q3 2018.

Weiss Multi-Strategy Advisers reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2018 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 67,929 Keryx Biopharmaceuticals Inc shares in Q3 2018, an estimated $255K.
Weiss Multi-Strategy Advisers first reported a position in Keryx Biopharmaceuticals Inc in Q4 2013 and held it in 14 quarters.
Weiss Multi-Strategy Advisers's Keryx Biopharmaceuticals Inc position peaked at $561K in Q4 2015.
123 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2018.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2018, filed 14 Nov 2018.